Common Contracts
3 similar Exclusive License Agreement contracts by Actuate Therapeutics, Inc.
EXCLUSIVE LICENSE AGREEMENT WITH EQUITYExclusive License Agreement • July 16th, 2024 • Actuate Therapeutics, Inc. • Pharmaceutical preparations • Illinois
License Agreement (“Agreement”), effective as of April 6, 2015 (“Effective Date”) between The Board Of Trustees Of The University Of Illinois, a body corporate and politic of the State of Illinois, 352 Henry Administration Building, 506 S. Wright St., Urbana, Illinois 61801 (“University”) and Apotheca Therapeutics a Delaware corporation, with a principal place of business at 1401 Foch Street, Fort Worth, TX 76107 (“Licensee” or “Company”).
EXCLUSIVE LICENSE AGREEMENT WITH EQUITYExclusive License Agreement • May 24th, 2024 • Actuate Therapeutics, Inc. • Pharmaceutical preparations • Illinois
License Agreement (“Agreement”), effective as of April 6, 2015 (“Effective Date”) between The Board Of Trustees Of The University Of Illinois, a body corporate and politic of the State of Illinois, 352 Henry Administration Building, 506 S. Wright St., Urbana, Illinois 61801 (“University”) and Apotheca Therapeutics a Delaware corporation, with a principal place of business at 1401 Foch Street, Fort Worth, TX 76107 (“Licensee” or “Company”).
EXCLUSIVE LICENSE AGREEMENT WITH EQUITYExclusive License Agreement • March 4th, 2024 • Actuate Therapeutics, Inc. • Services-commercial physical & biological research • Illinois
License Agreement (“Agreement”), effective as of April 6, 2015 (“Effective Date”) between The Board Of Trustees Of The University Of Illinois, a body corporate and politic of the State of Illinois, 352 Henry Administration Building, 506 S. Wright St., Urbana, Illinois 61801 (“University”) and Apotheca Therapeutics a Delaware corporation, with a principal place of business at 1401 Foch Street, Fort Worth, TX 76107 (“Licensee” or “Company”).
